Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02708433 · ClinicalTrials.gov registry record · NA

Clinical Outcomes of Buffered 1% Lidocaine vs. Non-buffered 2% Lidocaine

A NA study of Anesthesia, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
23
Enrollment target
1
Study location

NCT02708433 is a NA study of Anesthesia that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 23 participants, below the 109,410-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02708433, a NA study of Anesthesia, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
23 participants
Enrollment target
1
Study location

Study Summary

Anecdotal data suggest that the buffered form of the local anesthetic is more potent at equal dosages, and a lower dosage of the drug might be used with an effect equal to higher dosage not buffered. Clinical data are needed to confirm these anecdotal data. No data exist comparing buffered local anesthetics at lower drug concentrations to current dosages commonly used in dental and oral surgical procedures

Conditions Studied

Interventions

  • DRUG Lidocaine

Study Locations (1)

North Carolina

  • UNC School of Dentistry - Chapel Hill

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2016-03
Est. Completion 2017-09
Phase NA

What the Registry Record Tells You About NCT02708433

The ClinicalTrials.gov registry entry for NCT02708433 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 109,410-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Anesthesia appearing as the primary indexed condition, and to 1 intervention - of which Lidocaine is the first listed.

NCT02708433 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT02708433 about?

NCT02708433 is a clinical study titled "Clinical Outcomes of Buffered 1% Lidocaine vs. Non-buffered 2% Lidocaine". Anecdotal data suggest that the buffered form of the local anesthetic is more potent at equal dosages, and a lower dosage of the drug might be used with an effect equal to higher dosage not buffered. Clinical data are needed to confirm these anecdotal data. No data exist comparing buffered local ane...

What is the current status of trial NCT02708433?

This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2016-03. Estimated completion is 2017-09.

What conditions does trial NCT02708433 study?

This clinical trial studies the following conditions: Anesthesia.

What interventions are being tested in trial NCT02708433?

The interventions under investigation include: Lidocaine (DRUG).

Who is sponsoring clinical trial NCT02708433?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02708433 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anesthesia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.